GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardax Inc (OTCPK:CDXI) » Definitions » Piotroski F-Score

Cardax (Cardax) Piotroski F-Score : 0 (As of May. 03, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Cardax Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cardax has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Cardax's Piotroski F-Score or its related term are showing as below:


Cardax Piotroski F-Score Historical Data

The historical data trend for Cardax's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardax Piotroski F-Score Chart

Cardax Annual Data
Trend Mar12 Mar13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only 5.00 3.00 3.00 1.00 2.00

Cardax Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 3.00 2.00 3.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar21) TTM:Last Year (Mar20) TTM:
Net Income was -1.7 + -1.354 + -0.998 + -1.382 = $-5.43 Mil.
Cash Flow from Operations was -0.434 + -0.404 + -0.385 + -0.337 = $-1.56 Mil.
Revenue was 0.135 + 0.067 + 0.195 + 0.105 = $0.50 Mil.
Gross Profit was 0.096 + 0.039 + 0.128 + 0.066 = $0.33 Mil.
Average Total Assets from the begining of this year (Mar20)
to the end of this year (Mar21) was
(1.873 + 1.711 + 1.787 + 1.425 + 1.378) / 5 = $1.6348 Mil.
Total Assets at the begining of this year (Mar20) was $1.87 Mil.
Long-Term Debt & Capital Lease Obligation was $0.21 Mil.
Total Current Assets was $1.09 Mil.
Total Current Liabilities was $12.45 Mil.
Net Income was -1.082 + -1.434 + -1.442 + -1.003 = $-4.96 Mil.

Revenue was 0.045 + 0.229 + 0.271 + 0.143 = $0.69 Mil.
Gross Profit was 0.016 + 0.108 + 0.181 + 0.08 = $0.39 Mil.
Average Total Assets from the begining of last year (Mar19)
to the end of last year (Mar20) was
(2.289 + 2.089 + 2.114 + 2.019 + 1.873) / 5 = $2.0768 Mil.
Total Assets at the begining of last year (Mar19) was $2.29 Mil.
Long-Term Debt & Capital Lease Obligation was $1.00 Mil.
Total Current Assets was $1.44 Mil.
Total Current Liabilities was $8.37 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cardax's current Net Income (TTM) was -5.43. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cardax's current Cash Flow from Operations (TTM) was -1.56. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar20)
=-5.434/1.873
=-2.90122798

ROA (Last Year)=Net Income/Total Assets (Mar19)
=-4.961/2.289
=-2.16732197

Cardax's return on assets of this year was -2.90122798. Cardax's return on assets of last year was -2.16732197. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Cardax's current Net Income (TTM) was -5.43. Cardax's current Cash Flow from Operations (TTM) was -1.56. ==> -1.56 > -5.43 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar20 to Mar21
=0.211/1.6348
=0.12906778

Gearing (Last Year: Mar20)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar19 to Mar20
=1/2.0768
=0.48151002

Cardax's gearing of this year was 0.12906778. Cardax's gearing of last year was 0.48151002. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar21)=Total Current Assets/Total Current Liabilities
=1.088/12.45
=0.08738956

Current Ratio (Last Year: Mar20)=Total Current Assets/Total Current Liabilities
=1.443/8.374
=0.17231908

Cardax's current ratio of this year was 0.08738956. Cardax's current ratio of last year was 0.17231908. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Cardax's number of shares in issue this year was 0.794. Cardax's number of shares in issue last year was 0.701. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.329/0.502
=0.65537849

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.385/0.688
=0.55959302

Cardax's gross margin of this year was 0.65537849. Cardax's gross margin of last year was 0.55959302. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar20)
=0.502/1.873
=0.26801922

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar19)
=0.688/2.289
=0.30056793

Cardax's asset turnover of this year was 0.26801922. Cardax's asset turnover of last year was 0.30056793. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+1+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cardax has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Cardax  (OTCPK:CDXI) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Cardax Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Cardax's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardax (Cardax) Business Description

Traded in Other Exchanges
N/A
Address
2800 Woodlawn Drive, Suite 129, Honolulu, HI, USA, 96822
Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health products in the United States. The firm's platform has applications in arthritis, metabolic syndrome, liver disease, and cardiovascular disease, as well as macular degeneration and prostate disease. It is focused on the development of astaxanthin technologies. The group's product ZanthoSyn is marketed as a novel astaxanthin dietary supplement. Astaxanthin is a clinically studied ingredient with a safe anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health, and liver health. Geographically, it generates maximum revenue from the United States.
Executives
Paulson Capital Corp 10 percent owner 222 THIRD STREET, SUITE 2241, CAMBRIDGE MA 02142
Paulson Investment Company, Inc. 10 percent owner 5335 MEADOWS ROAD SUITE 465 LAKE OSWEGO OR 97035
Paulson Cardax Investments 1 Llc 10 percent owner 811 SW NAITO PKWY SUITE 300 PORTLAND OR 97204

Cardax (Cardax) Headlines

From GuruFocus

Cardax Reports Q3 2019 Results

By PRNewswire PRNewswire 11-14-2019

Cardax Reports Q1 2021 Results

By PRNewswire PRNewswire 05-14-2021

Cardax Announces Warrant Exchange Offer

By PRNewswire PRNewswire 05-03-2018

Cardax Reports Q1 2019 Results

By PRNewswire PRNewswire 05-17-2019

Cardax to Present at NobleCon XV

By PRNewswire PRNewswire 01-25-2019

Cardax Reports 2018 Results

By PRNewswire PRNewswire 03-28-2019

Cardax Reports Q3 2020 Results

By PRNewswire PRNewswire 11-14-2020